@trader1188 = still remember this word two months ago ( no body want u to listen to me !)
and what u post 2 month ago (Not 100% confirm but a friend of mine said they failed to comply with the strict T&C on GMP imposed by Cansino. Similar case like Doupharma, which they secured Sinopharm due to the existing co. failed to comply with the T&C. Better be safe than sorry due to the uncertainties....)
and now what u tell us the same things , no body want u to listen to me ???
@YOLOorLOL, what’s ur point? Is winning an argument in forum while losing money in d market will make u mightier n wiser. Rmmber the ultimate aim in trading/investing is to make money.
So if belittling me will make u make money? Pls go ahead! Good luck!
Good morning and Happy Malaysia Day. Looks like very likely the price will move sideway towards downside. Is still a good company too invest for a longer term but in short term, I don't see any possibility of high price fluctuation. Anyhow, that's my personal feeling and my study of this counter. Good luck to those who still hold the shares and happy holidays ......
I have a question... Indon is approved to entry cansino vaccine last week. I wonder the agreement deal with china or solution group? Cause the agreement was deal last year indon with china
@beltland Hannah..means u r olddies.... Hahahaha...and how much u earn for your whole life ..just 1 ringgit include agent fee hahahaha... I know u don't have to tell me.. And I don't bother to know... But honestly tell u.... I bought Genetec at 2.50 and n how much is the price now ?...... And I won't buy under 10 lots ... Lame Olddies show your result!!!
Of the more than 100 Covid-19 vaccines undergoing clinical studies recognised by the World Health Organization, eight are intranasal vaccines. These are designed to target the mucosa of the nose and throat area where the coronavirus first enters the body, and offer a different immune response. Last week, China’s CanSino Biologics published the results of an early-stage clinical trial which found that an aerosol inhaled version of its Ad5-nCoV vaccine – which is already approved for use in a single-dose, injectable form in China, Pakistan and Mexico – triggered immune responses without serious side effects. - SOuth China MorningPost
Told already..this counter if today green tomorrow straight red..be careful la glove billions2 also back to pre pandemic price..eh..ok la later that guy @ YOLOorLOL come here marah2 me...keh..keh
Be sensible when comes to investing. No point in holding the share when the market is bad plus no more catalyst to move the price. Cut and hold on to cash 1st, buy back when the time is right even though it might be months later.
yes ACBC. agreed with you. with the booster shot, there's additional revenue for solution. i read in the article saying that cansino's booster shot demonstrated an increase of at least 78-fold in average neutralising antibody levels. even for those ppl that took other vaccine.
abcb : ............ On 30 June 2021,SOLBIO had entered into 2 Supply Agreement('the Agreement) with CanSino Biologics Inc("CanSino') for the Supply of COVID-19 vaccine in both finished product and bulk form On 20 August 2021,SOLBIO delivered 200,000 doses of CanSino COVID-19 vaccines to MOH. This is the first delivery and SOLBIO is expecting to fullfil the supply of the 3.5 million doses to MOH,by fourth quarter of 2021
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Trader1188
251 posts
Posted by Trader1188 > 2021-09-15 18:11 | Report Abuse
My goodness! still believing in the vaccine fairy tales. The goreng theme already ended.